Tri Locum Partners LP Jazz Pharmaceuticals PLC Transaction History

Tri Locum Partners LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$126.59 - $161.18 $6.22 Million - $7.92 Million	49,165 Added 85.71%	106,528 $14.2 Million
Q2 2022 Aug 15, 2022	SELL	$141.59 - $168.66 $10.4 Million - $12.4 Million	-73,315 Reduced 56.1%	57,363 $8.95 Million
Q1 2022 May 16, 2022	BUY	$129.64 - $160.7 $16.9 Million - $21 Million	130,678 New	130,678 $20.3 Million
Q3 2021 Nov 15, 2021	SELL	$128.64 - $184.79 $11.5 Million - $16.5 Million	-89,370 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$160.2 - $186.42 $3.37 Million - $3.92 Million	-21,012 Reduced 19.04%	89,370 $15.9 Million
Q1 2021 May 17, 2021	BUY	$150.19 - $173.5 $16.6 Million - $19.2 Million	110,382 New	110,382 $18.1 Million

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.7B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Tri Locum Partners LP, based on Form 13F filings with the SEC.

Stay updated on Tri Locum Partners LP with notifications on news.